Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
about
Conjugated pneumococcal vaccine versus polysaccharide pneumococcal vaccine for prevention of pneumonia and invasive pneumococcal disease in immunocompetent and immunocompromised adults and childrenHow Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein AntigensPneumococcal Capsules and Their Types: Past, Present, and FutureInterim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacementPrevention of Community-Acquired Pneumonia with Available Pneumococcal VaccinesEpidemiology, virulence factors and management of the pneumococcusPneumococcal Disease in the Era of Pneumococcal Conjugate VaccineFrom the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhoodPopulation structure of invasive Streptococcus pneumoniae isolates among Alaskan children in the conjugate vaccine era, 2001 to 2013.Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.Trends of vaccine-preventable diseases in Afghanistan from the Disease Early Warning System, 2009-2015.Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world.Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.Cost-effectiveness of pneumococcal vaccination strategies for the elderly in KoreaEffectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies.Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage, United States, 2015-2016.Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South AfricaConcurrent Infection with Hepatitis C Virus and Streptococcus pneumoniae.In Vitro Activity of Lefamulin Tested against Streptococcus pneumoniae with Defined Serotypes, Including Multidrug-Resistant Isolates Causing Lower Respiratory Tract Infections in the United StatesReply to Farkouh RA et al. Comment on "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children"Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA.Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adultsDecision-Making and the Barriers to Judicious Antibiotic Use.Clinical characteristics of the patients with bacteremia due to Moraxella catarrhalis in children: a case-control study.Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, SpainCultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections.Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young childrenEffectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in GermanySerotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012-2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes.In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia.Racial and Regional Differences in Rates of Invasive Pneumococcal Disease.Assignment of Weight-Based Antibody Units for Seven Additional Serotypes to a Human Pneumococcal Standard Reference Serum, 007sp.Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia.Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis.Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.Increased incidence of adult pneumococcal pneumonia during school holiday periods.Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain.
P2860
Q26470649-FAB4A27E-80B9-4488-8C53-8FC2D1A2ED6CQ26748155-4EE99C02-140E-4AE5-98CE-49E48B16063BQ26753152-B2513A1D-BDF5-4CBA-8D55-D2DB4070CF76Q27006887-D05C0B34-0315-4239-BD2E-812A7316FE00Q28069508-3B236481-098D-48AB-93F0-AF2DC15692B7Q28077703-E887D7B5-3A93-4CC6-AD5B-9A02EF2A479FQ28078832-9CBACE0F-DDBE-4025-98D2-EE29486E42F5Q28088610-F478DD3B-3C40-4444-B428-65834F0A63A5Q29248091-C4E2F7E4-7409-4E1C-8958-E4B7A7D92853Q30151859-F344C0A3-E906-4811-8063-185130917295Q30251593-668095BA-890F-4499-B7CC-6D79FA6A838EQ30376283-A20D45B1-4DD6-43F5-9581-C738046F7932Q31157042-9E3C60F5-DB90-4137-839C-9274DF766BCDQ33653107-506DEF9C-85F8-4005-91B1-F42A45365840Q33675229-EA19B487-D93C-4C63-B6A5-057A8FAE0C57Q33719116-D21F93ED-655E-403D-9E93-BE7307BCB809Q33724635-BF0FEFF3-A4E6-47C2-8AFE-A425EF78227AQ33865533-39DD4315-030C-434A-AD51-23A417A4FB24Q33908082-5F53E861-A699-4891-AE91-2F097351E6FEQ34525879-9458A42D-25EB-45C9-A91E-1E7C70140F18Q35752770-07B295B6-023C-40C6-BE90-65E80C1192AFQ35771614-7AD87E3C-11D6-4A31-997B-BF5FCCA6EBC7Q35886948-BC77C359-39C9-4570-810A-E0969DE44568Q35894792-BDBB1FCE-8E7E-403D-BD88-1A0D0967A5A2Q35919024-1EC0C808-FB8D-4D60-8AAA-4425630D64A2Q35949066-ADB53B17-7FE6-481A-A0DC-AAA9D6C64318Q35997524-36CD7E6B-E389-480A-A41A-34BFBFDE4545Q36099559-AC451D58-0A2F-45FF-8696-1E35268A6527Q36104219-05F72E7E-13E4-42B8-A455-9422D941659BQ36176772-55010828-0CF3-4F07-BF9C-9C01773E41C2Q36209314-9F5D018D-3F2D-426F-8CA3-8C2946723F94Q36210595-413ECC27-7D3C-44E0-AF7A-67A35BE0F66DQ36211646-09325628-39EB-4E6F-A335-B2795450D942Q36212139-6F28C8A3-C9CD-4BE3-969D-8163AF85A535Q36229752-2036D096-8A2B-4C95-A7A8-8A7ABEC52CDDQ36243016-D6065F54-8AD1-48A6-9AD4-3FEE229E3EB5Q36283007-91FD6588-1C42-404A-ADB3-5911DC4B7130Q36294177-35EBC709-FBB7-48FB-9753-36EC234C0453Q36317193-5FD7CC53-E224-42B5-8C18-1C017D75A6D0Q36338543-FC96E72E-5A4A-4717-8A71-6D54D18FACCF
P2860
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Effect of use of 13-valent pne ...... population-based surveillance
@en
type
label
Effect of use of 13-valent pne ...... population-based surveillance
@en
prefLabel
Effect of use of 13-valent pne ...... population-based surveillance
@en
P2093
P2860
P1476
Effect of use of 13-valent pne ...... population-based surveillance
@en
P2093
Ann Thomas
Arthur Reingold
Bernard Beall
Catherine Lexau
Cynthia G Whitney
Elizabeth R Zell
James H Jorgensen
Karen Scherzinger
Lee H Harrison
Lesley McGee
P2860
P304
P356
10.1016/S1473-3099(14)71081-3
P577
2015-02-03T00:00:00Z